Home LiteratureArticle Details
PMID: 20231695 Published · ppublish English Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis [corrected].

Journal of immunology (Baltimore, Md. : 1950) ·Vol. 184 ·No. 8 ·2010-04-15 ·Pages 4497-509

Penzo M, Molteni R, Suda T, Samaniego S, Raucci A, Habiel DM, Miller F, Jiang HP, Li J, Pardi R, Palumbo R, Olivotto E, Kew RR, Bianchi ME, Marcu KB

Abstract

Inhibitor of NF-kappaB kinases beta (IKKbeta) and alpha (IKKalpha) activate distinct NF-kappaB signaling modules. The IKKbeta/canonical NF-kappaB pathway rapidly responds to stress-like conditions, whereas the IKKalpha/noncanonical pathway controls adaptive immunity. Moreover, IKKalpha can attenuate IKKbeta-initiated inflammatory responses. High mobility group box 1 (HMGB1), a chromatin protein, is an extracellular signal of tissue damage-attracting cells in inflammation, tissue regeneration, and scar formation. We show that IKKalpha and IKKbeta are each critically important for HMGB1-elicited chemotaxis of fibroblasts, macrophages, and neutrophils in vitro and neutrophils in vivo. By time-lapse microscopy we dissected different parameters of the HMGB1 migration response and found that IKKalpha and IKKbeta are each essential to polarize cells toward HMGB1 and that each kinase also differentially affects cellular velocity in a time-dependent manner. In addition, HMGB1 modestly induces noncanonical IKKalpha-dependent p52 nuclear translocation and p52/RelB target gene expression. Akin to IKKalpha and IKKbeta, p52 and RelB are also required for HMGB1 chemotaxis, and p52 is essential for cellular orientation toward an HMGB1 gradient. RAGE, a ubiquitously expressed HMGB1 receptor, is required for HMGB1 chemotaxis. Moreover, IKKbeta, but not IKKalpha, is required for HMGB1 to induce RAGE mRNA, suggesting that RAGE is at least one IKKbeta target involved in HMGB1 migration responses, and in accord with these results enforced RAGE expression rescues the HMGB1 migration defect of IKKbeta, but not IKKalpha, null cells. Thus, proinflammatory HMGB1 chemotactic responses mechanistically require the differential collaboration of both IKK-dependent NF-kappaB signaling pathways.

MeSH Terms
Animals Cells, Cultured Chemotaxis/genetics,immunology Fibroblasts/cytology,enzymology,immunology HMGB1 Protein/physiology I-kappa B Kinase/deficiency,genetics,physiology Macrophages/cytology,enzymology,immunology Mice Mice, Knockout Mice, Transgenic Neutrophils/cytology,enzymology,immunology Recombinant Proteins/pharmacology Signal Transduction/genetics,immunology
Chemicals
HMGB1 Protein Recombinant Proteins Chuk protein, mouse I-kappa B Kinase Ikbkb protein, mouse
Authors & Affiliations
15 authors, click to expand affiliations / ORCID
Penzo Marianna
Vita-Salute San Raffaele University, School of Medicine, San Raffaele Scientific Institute, Milano, Italy.
Molteni Raffaella
Suda Tomomi
Samaniego Sylvia
Raucci Angela
Habiel David M
Miller Frederick
Jiang Hui-Ping
Li Jun
Pardi Ruggero
Palumbo Roberta
Olivotto Eleonora
Kew Richard R
Bianchi Marco E
Marcu Kenneth B
References (80)
80 references, click to expand
  1. HMGB1 loves company.
    J Leukoc Biol. 2009 Sep;86(3):573-6 PMID: 19414536
  2. Requirement of HMGB1 for stromal cell-derived factor-1/CXCL12-dependent migration of macrophages and dendritic cells.
    J Leukoc Biol. 2009 Sep;86(3):609-15 PMID: 19414537
  3. The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.
    J Leukoc Biol. 2009 Sep;86(3):655-62 PMID: 19564572
  4. Mouse bone marrow contains large numbers of functionally competent neutrophils.
    J Leukoc Biol. 2004 Apr;75(4):604-11 PMID: 14694182
  5. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis.
    Nature. 2004 Apr 8;428(6983):660-4 PMID: 15071597
  6. IkappaB kinases: key regulators of the NF-kappaB pathway.
    Trends Biochem Sci. 2004 Feb;29(2):72-9 PMID: 15102433
  7. The two NF-kappaB activation pathways and their role in innate and adaptive immunity.
    Trends Immunol. 2004 Jun;25(6):280-8 PMID: 15145317
  8. Activation of IKKalpha target genes depends on recognition of specific kappaB binding sites by RelB:p52 dimers.
    EMBO J. 2004 Oct 27;23(21):4202-10 PMID: 15470505
  9. Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor.
    J Exp Med. 1973 Feb 1;137(2):387-410 PMID: 4568301
  10. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family.
    J Immunol. 1993 Sep 1;151(5):2399-408 PMID: 8360469
  11. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.
    Am J Pathol. 1993 Dec;143(6):1699-712 PMID: 8256857
  12. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
    J Biol Chem. 1995 Oct 27;270(43):25752-61 PMID: 7592757
  13. Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines.
    J Exp Med. 1996 Mar 1;183(3):867-78 PMID: 8642291
  14. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products.
    J Biol Chem. 1997 Jun 27;272(26):16498-506 PMID: 9195959
  15. HMGB1 enhances the proinflammatory activity of lipopolysaccharide by promoting the phosphorylation of MAPK p38 through receptor for advanced glycation end products.
    J Immunol. 2009 Nov 15;183(10):6244-50 PMID: 19890065
  16. Ligand-activated site-specific recombination in mice.
    Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10887-90 PMID: 8855277
  17. Temporally-controlled site-specific mutagenesis in the basal layer of the epidermis: comparison of the recombinase activity of the tamoxifen-inducible Cre-ER(T) and Cre-ER(T2) recombinases.
    Nucleic Acids Res. 1999 Nov 15;27(22):4324-7 PMID: 10536138
  18. Conditional gene targeting in macrophages and granulocytes using LysMcre mice.
    Transgenic Res. 1999 Aug;8(4):265-77 PMID: 10621974
  19. IKKalpha controls formation of the epidermis independently of NF-kappaB.
    Nature. 2001 Apr 5;410(6829):710-4 PMID: 11287960
  20. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.
    Nature. 2002 Jul 11;418(6894):191-5 PMID: 12110890
  21. The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways.
    Immunity. 2002 Oct;17(4):525-35 PMID: 12387745
  22. HMGB1 as a DNA-binding cytokine.
    J Leukoc Biol. 2002 Dec;72(6):1084-91 PMID: 12488489
  23. Rapid generation of inducible mouse mutants.
    Nucleic Acids Res. 2003 Feb 15;31(4):e12 PMID: 12582257
  24. A noninvasive genetic/pharmacologic strategy for visualizing cell morphology and clonal relationships in the mouse.
    J Neurosci. 2003 Mar 15;23(6):2314-22 PMID: 12657690
  25. A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts.
    J Biol Chem. 2003 Aug 29;278(35):32861-71 PMID: 12813046
  26. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
    J Biol Chem. 2003 Sep 19;278(38):36005-12 PMID: 12840022
  27. Cell migration.
    Curr Biol. 2003 Sep 30;13(19):R756-9 PMID: 14521851
  28. Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.
    EMBO J. 2003 Oct 15;22(20):5551-60 PMID: 14532127
  29. Cell migration: integrating signals from front to back.
    Science. 2003 Dec 5;302(5651):1704-9 PMID: 14657486
  30. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation.
    J Cell Biol. 2004 Feb 2;164(3):441-9 PMID: 14744997
  31. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo.
    J Exp Med. 1998 Sep 21;188(6):1029-37 PMID: 9743521
  32. Limb and skin abnormalities in mice lacking IKKalpha.
    Science. 1999 Apr 9;284(5412):313-6 PMID: 10195895
  33. Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase.
    Science. 1999 Apr 9;284(5412):316-20 PMID: 10195896
  34. IKK1-deficient mice exhibit abnormal development of skin and skeleton.
    Genes Dev. 1999 May 15;13(10):1322-8 PMID: 10346820
  35. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages.
    Scand J Immunol. 2005 Jan;61(1):1-9 PMID: 15644117
  36. Essential role of IkappaB kinase alpha in the constitutive processing of NF-kappaB2 p100.
    J Biol Chem. 2005 Mar 18;280(11):9765-8 PMID: 15677466
  37. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal.
    Nat Rev Immunol. 2005 Apr;5(4):331-42 PMID: 15803152
  38. Gene expression profiling in conjunction with physiological rescues of IKKalpha-null cells with wild type or mutant IKKalpha reveals distinct classes of IKKalpha/NF-kappaB-dependent genes.
    J Biol Chem. 2005 Apr 8;280(14):14057-69 PMID: 15695520
  39. IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation.
    Nature. 2005 Apr 28;434(7037):1138-43 PMID: 15858576
  40. p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.
    Genes Dev. 2005 May 15;19(10):1175-87 PMID: 15870258
  41. Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).
    Proc Natl Acad Sci U S A. 2005 Aug 30;102(35):12425-30 PMID: 16116086
  42. Interferon induces NF-kappa B-inducing kinase/tumor necrosis factor receptor-associated factor-dependent NF-kappa B activation to promote cell survival.
    J Biol Chem. 2005 Sep 9;280(36):31530-6 PMID: 16009713
  43. NF-kappaB: linking inflammation and immunity to cancer development and progression.
    Nat Rev Immunol. 2005 Oct;5(10):749-59 PMID: 16175180
  44. Understanding RAGE, the receptor for advanced glycation end products.
    J Mol Med (Berl). 2005 Nov;83(11):876-86 PMID: 16133426
  45. Selective inhibition of the C5a chemotactic cofactor function of the vitamin D binding protein by 1,25(OH)2 vitamin D3.
    Mol Immunol. 2006 Mar;43(8):1109-15 PMID: 16115686
  46. High mobility group box 1 protein interacts with multiple Toll-like receptors.
    Am J Physiol Cell Physiol. 2006 Mar;290(3):C917-24 PMID: 16267105
  47. Promotion of cell adherence and spreading: a novel function of RAGE, the highly selective differentiation marker of human alveolar epithelial type I cells.
    Cell Tissue Res. 2006 Mar;323(3):475-88 PMID: 16315007
  48. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    J Biol Chem. 2006 Mar 24;281(12):8242-53 PMID: 16407300
  49. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2.
    Shock. 2006 Aug;26(2):174-9 PMID: 16878026
  50. IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.
    Oncogene. 2006 Oct 30;25(51):6685-705 PMID: 17072322
  51. Integrating cell-signalling pathways with NF-kappaB and IKK function.
    Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62 PMID: 17183360
  52. Pivotal advance: analysis of proinflammatory activity of highly purified eukaryotic recombinant HMGB1 (amphoterin).
    J Leukoc Biol. 2007 Jan;81(1):49-58 PMID: 16980512
  53. The secretion of HMGB1 is required for the migration of maturing dendritic cells.
    J Leukoc Biol. 2007 Jan;81(1):84-91 PMID: 17035340
  54. IkappaB kinase subunits alpha and gamma are required for activation of NF-kappaB and induction of apoptosis by mammalian reovirus.
    J Virol. 2007 Feb;81(3):1360-71 PMID: 17121808
  55. A fourth IkappaB protein within the NF-kappaB signaling module.
    Cell. 2007 Jan 26;128(2):369-81 PMID: 17254973
  56. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin.
    EMBO J. 2007 Feb 21;26(4):1129-39 PMID: 17268551
  57. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE.
    Nat Immunol. 2007 May;8(5):487-96 PMID: 17417641
  58. Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.
    Cell. 2007 Jun 1;129(5):903-14 PMID: 17540171
  59. Receptor for advanced glycation end products (RAGE) in a dash to the rescue: inflammatory signals gone awry in the primal response to stress.
    J Leukoc Biol. 2007 Aug;82(2):204-12 PMID: 17513693
  60. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
    Cancer Res. 2007 Aug 1;67(15):7368-77 PMID: 17671207
  61. A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.
    Blood. 2007 Sep 15;110(6):1970-81 PMID: 17548579
  62. Lymph node chemokines promote sustained T lymphocyte motility without triggering stable integrin adhesiveness in the absence of shear forces.
    Nat Immunol. 2007 Oct;8(10):1076-85 PMID: 17721537
  63. Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-kappaB activation.
    J Cell Biol. 2007 Oct 8;179(1):33-40 PMID: 17923528
  64. Src tyrosine kinases mediate activations of NF-kappaB and integrin signal during lipopolysaccharide-induced acute lung injury.
    J Immunol. 2007 Nov 15;179(10):7001-11 PMID: 17982091
  65. HMGB1 develops enhanced proinflammatory activity by binding to cytokines.
    J Immunol. 2008 Feb 15;180(4):2531-7 PMID: 18250463
  66. Shared principles in NF-kappaB signaling.
    Cell. 2008 Feb 8;132(3):344-62 PMID: 18267068
  67. Thrombin-induced IL-6 production in human synovial fibroblasts is mediated by PAR1, phospholipase C, protein kinase C alpha, c-Src, NF-kappa B and p300 pathway.
    Mol Immunol. 2008 Mar;45(6):1587-99 PMID: 18062909
  68. IKKalpha is a critical coregulator of a Smad4-independent TGFbeta-Smad2/3 signaling pathway that controls keratinocyte differentiation.
    Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2487-92 PMID: 18268325
  69. High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes.
    J Immunol. 2008 Apr 1;180(7):5067-74 PMID: 18354232
  70. A CD28 superagonistic antibody elicits 2 functionally distinct waves of T cell activation in rats.
    J Clin Invest. 2008 Apr;118(4):1405-16 PMID: 18357346
  71. PTEN functions to 'prioritize' chemotactic cues and prevent 'distraction' in migrating neutrophils.
    Nat Immunol. 2008 Jul;9(7):743-52 PMID: 18536720
  72. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
    FASEB J. 2008 Oct;22(10):3716-27 PMID: 18603587
  73. Sustained NF-kappaB activation produces a short-term cell proliferation block in conjunction with repressing effectors of cell cycle progression controlled by E2F or FoxM1.
    J Cell Physiol. 2009 Jan;218(1):215-27 PMID: 18803232
  74. The HMGB1 receptor RAGE mediates ischemic brain damage.
    J Neurosci. 2008 Nov 12;28(46):12023-31 PMID: 19005067
  75. Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.
    J Biol Chem. 2008 Dec 5;283(49):34457-68 PMID: 18922799
  76. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.
    J Exp Med. 2008 Dec 22;205(13):3007-18 PMID: 19064698
  77. Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses.
    J Biochem. 2009 Jan;145(1):21-30 PMID: 18849572
  78. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo.
    Shock. 2009 Mar;31(3):280-4 PMID: 19218854
  79. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.
    FASEB J. 2009 Jun;23(6):1766-74 PMID: 19164451
  80. Src family kinases are necessary for cell migration induced by extracellular HMGB1.
    J Leukoc Biol. 2009 Sep;86(3):617-23 PMID: 19401391
Article Info
Journal
Journal of immunology (Baltimore, Md. : 1950)
Abbr.
J Immunol
ISSN
1550-6606
Published
2010-04-15
Epub
2010-00-15
Pages
4497-509
Language
English
Region
United States
NLM ID
2985117R
PMCID
PMC2915896
Subset
IM
Grants
NIGMS NIH HHS · R01 GM063769 · United States
NIGMS NIH HHS · R01 GM063769-07 · United States
NIGMS NIH HHS · 5T32 GM008468 · United States
NIGMS NIH HHS · R01 GM066882-04 · United States
NIGMS NIH HHS · GM063769 · United States
NIGMS NIH HHS · GM066882 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com